抗菌药物治疗药物监测有哪些新进展？ - Suppr

Suppr

超能文献

What's new in therapeutic drug monitoring of antimicrobials?

作者信息

Sjövall Fredrik, Lanckohr Christian, Bracht Hendrik

机构信息

Intensive and perioperative medicine, Skane university hospital, Malmö, Sweden.

Antibiotic Stewardship (ABS)-Team, Institut of Hygiene, University Hospital Münster, Münster, Germany.

出版信息

Intensive Care Med. 2023 Jul;49(7):857-859. doi: 10.1007/s00134-023-07060-5. Epub 2023 May 3.

DOI:10.1007/s00134-023-07060-5

PMID:37133741

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10353963/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acf3/10353963/7ee7cd99e2ce/134_2023_7060_Fig1_HTML.jpg

相似文献

What's new in therapeutic drug monitoring of antimicrobials?

Intensive Care Med. 2023 Jul;49(7):857-859. doi: 10.1007/s00134-023-07060-5. Epub 2023 May 3.

[Therapeutic drug monitoring of antiinfectives in intensive care unit patients - what's new?].

Dtsch Med Wochenschr. 2020 Dec;145(24):1764-1769. doi: 10.1055/a-1207-1914. Epub 2020 Nov 30.

[Therapeutic drug monitoring of antimicrobials].

Ned Tijdschr Geneeskd. 2014;158:A7520.

What's new in pharmacokinetics of antimicrobials in AKI and RRT?

Intensive Care Med. 2017 Jun;43(6):904-906. doi: 10.1007/s00134-017-4789-x. Epub 2017 Apr 6.

Therapeutic drug monitoring of antimicrobials.

Ann Clin Biochem. 2016 May;53(Pt 3):333-46. doi: 10.1177/0004563215618981. Epub 2015 Nov 10.

Therapeutic monitoring of antimicrobials: a summary of the information presented at the UK NEQAS for antibiotic Assays meeting for participants, October 1993.

J Antimicrob Chemother. 1995 Jan;35(1):213-26. doi: 10.1093/jac/35.1.213.

What's new about gatifloxacin (Tequin)?

Urol Nurs. 2002 Oct;22(5):343-5.

What's new in antimicrobial use and resistance in critically ill patients?

Intensive Care Med. 2014 Mar;40(3):422-6. doi: 10.1007/s00134-013-3190-7. Epub 2013 Dec 18.

Special Issue on the Therapeutic Drug Monitoring of Anti-infective Drugs: Editorial.

Ther Drug Monit. 2022 Feb 1;44(1):1-2. doi: 10.1097/FTD.0000000000000951.

[Therapeutic Drug Monitoring of Antimicrobial Agents].

Rinsho Byori. 2016 Dec;64(12):1367-1372.

引用本文的文献

The Changing Landscape of Antibiotic Treatment: Reevaluating Treatment Length in the Age of New Agents.

Antibiotics (Basel). 2025 Jul 20;14(7):727. doi: 10.3390/antibiotics14070727.

A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: a strategy useful for raising the bar?

J Antimicrob Chemother. 2025 Mar 24;80(6):1543-51. doi: 10.1093/jac/dkaf098.

Antibiotic dosing optimization in critically ill patients.

Intensive Care Med. 2025 Mar;51(3):603-606. doi: 10.1007/s00134-025-07822-3. Epub 2025 Mar 10.

Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study.

Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7747-7756. doi: 10.1007/s00210-024-03136-1. Epub 2024 May 7.

Revolutionizing healthcare: the role of artificial intelligence in clinical practice.

BMC Med Educ. 2023 Sep 22;23(1):689. doi: 10.1186/s12909-023-04698-z.

本文引用的文献

Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial.

Intensive Care Med. 2022 Dec;48(12):1760-1771. doi: 10.1007/s00134-022-06921-9. Epub 2022 Nov 9.

Assessment of current practice for β-lactam therapeutic drug monitoring in French ICUs in 2021: a nationwide cross-sectional survey.

J Antimicrob Chemother. 2022 Sep 30;77(10):2650-2657. doi: 10.1093/jac/dkac291.

Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software.

Intensive Care Med. 2022 Oct;48(10):1338-1351. doi: 10.1007/s00134-022-06847-2. Epub 2022 Aug 23.

Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis.

Clin Infect Dis. 2022 Nov 14;75(10):1848-1860. doi: 10.1093/cid/ciac506.

Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients.

Crit Care. 2022 Jun 14;26(1):178. doi: 10.1186/s13054-022-04050-9.

A systematic review of the effect of therapeutic drug monitoring on patient health outcomes during treatment with penicillins.

J Antimicrob Chemother. 2022 May 29;77(6):1532-1541. doi: 10.1093/jac/dkac101.

Int J Antimicrob Agents. 2022 May;59(5):106569. doi: 10.1016/j.ijantimicag.2022.106569. Epub 2022 Mar 11.

Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.

Intensive Care Med. 2022 Mar;48(3):311-321. doi: 10.1007/s00134-021-06609-6. Epub 2022 Feb 1.

Combination of Pharmacokinetic and Pathogen Susceptibility Information To Optimize Meropenem Treatment of Gram-Negative Infections in Critically Ill Patients.

Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0183121. doi: 10.1128/AAC.01831-21. Epub 2021 Dec 6.

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Intensive Care Med. 2021 Nov;47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. Epub 2021 Oct 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验